The lack of an increased CV risk in SUSTAIN 6 and PIONEER 6 is consistent with evidence from a meta-analysis summarizing data from SUSTAIN and PIONEER glycemic efficacy trials, which included patients with T2D at relatively low CV risk ( Cardiovascular Safety of Other GLP-1RAS To date, seven CVOTs have been conducted with GLP-1RAs ( Figure 2
This is why GLP-1 weight management should be approached as part of a broader long-term treatment plan rather than a short-term fix
If you qualify for a Special Enrollment Period (SEP), you can make changes outside of the traditional enrollment periods
leptin, glucagon, glucose dependent insulinotropic peptide) 6,39,40,41,42
If someone in a gas station, smoke shop or over the internet touts the benefits of a non-FDA-approved drug product for pain or anxiety relief, to increase energy or for a buzz be aware